1. Samidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar rats.
- Author
-
Cunningham JI, Todtenkopf MS, Dean RL, Azar MR, Koob GF, Deaver DR, and Eyerman DJ
- Subjects
- Amphetamine pharmacology, Animals, Cocaine pharmacology, Ethanol pharmacology, Humans, Male, Microdialysis methods, Naltrexone pharmacology, Nucleus Accumbens metabolism, Oxycodone pharmacology, Rats, Rats, Wistar, Receptors, Opioid, mu metabolism, Self Administration methods, Dopamine metabolism, Naltrexone analogs & derivatives, Narcotic Antagonists pharmacology, Receptors, Opioid metabolism, Substance-Related Disorders metabolism
- Abstract
Opioid receptors modulate neurochemical and behavioral responses to drugs of abuse in nonclinical models. Samidorphan (SAM) is a new molecular entity that binds with high affinity to human mu- (μ), kappa- (κ), and delta- (δ) opioid receptors and functions as a μ-opioid receptor antagonist with partial agonist activity at κ- and δ-opioid receptors. Based on its in vitro profile, we hypothesized that SAM would block key neurobiological effects of drugs of abuse. Therefore, we assessed the effects of SAM on ethanol-, oxycodone-, cocaine-, and amphetamine-induced increases in extracellular dopamine (DA
ext ) in the nucleus accumbens shell (NAc-sh), and ethanol and cocaine self-administration behavior in rats. In microdialysis studies, administration of SAM alone did not result in measurable changes in NAc-sh DAext when given across a large range of doses. However, SAM markedly decreased average and maximal increases in NAc-sh DAext produced by each of the drugs of abuse tested. In behavioral studies, SAM attenuated fixed-ratio ethanol self-administration and progressive ratio cocaine self-administration. These results highlight the potential of SAM to counteract the neurobiological and behavioral effects of several drugs of abuse with differing mechanisms of action., (Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF